2023
DOI: 10.23736/s2784-8671.23.07373-5
|View full text |Cite
|
Sign up to set email alerts
|

Subacute cutaneous lupus erythematosus induced by Pfizer COVID-19 vaccine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…3,4 In this regard, the laboratory findings, particularly the autoantibody profile, may serve as a biomarker to differentiate between the two conditions. Accordingly, we recently described a subacute cutaneous lupus erythematosus (SCLE) presenting after Pfizer COVID-19 vaccination but serologically negative, 5 with no signs of recurrence nearly 2 years later. In a similar manner, drug-induced cases of dermatomyositis (DM) have been mostly reported to be characterized by pathognomic skin findings (85%) and negative serological markers.…”
Section: Reply To 'New Onset Of Systemic Lupus Erythematosus Followin...mentioning
confidence: 99%
“…3,4 In this regard, the laboratory findings, particularly the autoantibody profile, may serve as a biomarker to differentiate between the two conditions. Accordingly, we recently described a subacute cutaneous lupus erythematosus (SCLE) presenting after Pfizer COVID-19 vaccination but serologically negative, 5 with no signs of recurrence nearly 2 years later. In a similar manner, drug-induced cases of dermatomyositis (DM) have been mostly reported to be characterized by pathognomic skin findings (85%) and negative serological markers.…”
Section: Reply To 'New Onset Of Systemic Lupus Erythematosus Followin...mentioning
confidence: 99%